Targeted Retreatment of Incompletely Resolved COPD Exacerbations With Ciprofloxacin

A. Ritchie (London, United Kingdom), S. Brill (London, United Kingdom), B. Vlies (Liverpool, United Kingdom), L. Finney (London, United Kingdom), J. Allinson (London, United Kingdom), L. Alves-Moreira (London, United Kingdom), P. Walker (Liverpool, United Kingdom), E. Baker (London, United Kingdom), S. Elkin (London, United Kingdom), P. Mallia (London, United Kingdom), G. Donaldson (London, United Kingdom), P. Calverley (Liverpool, United Kingdom), J. Wedzicha (London, United Kingdom)

Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Session: COPD clinical studies: bronchodilators, corticosteroids and more
Session type: Poster Discussion
Number: 3386
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Ritchie (London, United Kingdom), S. Brill (London, United Kingdom), B. Vlies (Liverpool, United Kingdom), L. Finney (London, United Kingdom), J. Allinson (London, United Kingdom), L. Alves-Moreira (London, United Kingdom), P. Walker (Liverpool, United Kingdom), E. Baker (London, United Kingdom), S. Elkin (London, United Kingdom), P. Mallia (London, United Kingdom), G. Donaldson (London, United Kingdom), P. Calverley (Liverpool, United Kingdom), J. Wedzicha (London, United Kingdom). Targeted Retreatment of Incompletely Resolved COPD Exacerbations With Ciprofloxacin. 3386

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inappropriate Utilization of Antibiotics in COPD Exacerbations
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019


Audit of Duration of Corticosteroid Treatment in Acute Exacerbations of COPD
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018


Clinical Efficacy and Cost-Effectiveness Analysis of Cefepime or Piperacillin/tazobactam both with Ciprofloxacin in MICU Patients with Severe Pneumonia
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019

Methylprednisolone pulse therapy in Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020


Low Level of  Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease
Source: International Congress 2017 – COPD biomarkers
Year: 2017

The Relationship Between Symptoms, Exacerbations And Treatment Response in Bronchiectasis
Source: Virtual Congress 2020 – Bronchiectasis: epidemiology, endotyping and therapy
Year: 2020




Blood Eosinophils Correlate With Severe Exacerbations in Frequent Exacerbator Phenotype of COPD
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Mechanisms of Acute Exacerbations in COPD
Source: ERS Lung Science Conference 2019
Year: 2019

Assessment of Efficacy Omalizumab Retreatment in Patients With Severe Asthma
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018

Smart Watch-based Coaching with Tiotropium and Olodaterol Ameliorates Physical Activity in Chronic Obstructive Pulmonary Disease Patients
Source: International Congress 2017 – Bronchodilators and bronchoprotectors
Year: 2017


Metered Cryospray Modulates Bronchial Epithelial Gene Expression in Patients with Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Interventional pulmonology: unity in diversity
Year: 2020


Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD.
Source: International Congress 2017 – COPD biomarkers
Year: 2017


Microbiome Use to Stratify Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (MUSIC) trial: baseline data and impact of inhaled corticosteroid withdrawal in severe COPD with frequent exacerbations
Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Year: 2020


Role of Comorbidities and BMI on the Efficacy of Non Invasive Ventilation in COPD with Chronic Hypercapnia.
Source: International Congress 2018 – Non-invasive ventilation in chronic respiratory failure
Year: 2018


Does a Tailored Intervention to Promote Adherence in Patients with Chronic Lung Disease Affect Exacerbations?
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019

Late Breaking Abstract -  Bacterial Load and Inflammation in Sputum from patients with Alpha-1-Antitrypsin Deficiency as compared with COPD Patients
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017



Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Nasal High-flow Versus Non-invasive Ventilation In Patients With Chronic Hypercapnic COPD
Source: Virtual Congress 2020 – ALERT: Ventilation and rehabilitation
Year: 2020



Half Dose Urokinase Can Be Effective in Patients with Complicated Parapneumonic Effusion.
Source: International Congress 2017 – From microbiology to clinical work
Year: 2017